Ayumi Taguchi

Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Kōichi Goto, Yasushi Goto, Toshio Kubo et al. · Journal of Clinical Oncology · 2023 · 299 citations · Full text

Medicine, Oncology, Pharmacology +17

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety et al. · The Lancet Oncology · 2024 · 156 citations · Full text

Medicine, Oncology, Pharmacology +16

Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations

Satoshi Inoue, Yasushi Hirota, Toshihide Ueno et al. · Nature Communications · 2019 · 139 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis

Mariko Miyashita‐Ishiwata, Kaori Koga, Gentaro Izumi et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 122 citations · Full text

Medicine, Endocrinology, Gynecology +11

Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients

Kei Kawana, Katsuyuki Adachi, Satoko Kojima et al. · Vaccine · 2014 · 110 citations

Medicine, Immunology, Oncology +17